All‐cause and cause‐specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists

BACKGROUND: Mortality is increased in rheumatoid arthritis (RA), mainly because of cardiovascular (CV) events, cancer and infections. Recent data suggest that treatment with tumour necrosis factor (TNF) antagonists may affect this trend. OBJECTIVE: To assess whether treatment with TNF antagonists is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Carmona, Loreto, Descalzo, Miguel Ángel, Perez‐Pampin, Eva, Ruiz‐Montesinos, Dolores, Erra, Alba, Cobo, Tatiana, Gómez‐Reino, Juan J
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2007
Assuntos:
Extended Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1955107/
https://ncbi.nlm.nih.gov/pubmed/17324968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.067660
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados